Moderna starts testing its vaccine among teens

Moderna (MRNA.US) announced today that it has begun a phase 2/3 clinical trial designed to position its COVID-19 vaccine for use in children aged 12 to less than 18 before the start of the 2021-22 school year. The drugmaker has dosed the first participant in a study expected to enroll 3,000 healthy people. The study is being conducted in collaboration with the Biomedical Advanced Research and Development Authority (BARDA). "Our goal is to generate data in the spring of 2021 that will support the use of mRNA-1273 in adolescents in advance of the 2021 school year," said Chief Executive Officer Stéphane Bancel. Meanwhile US FDA will meet on December 17th to discuss whether to recommend the use of Moderna's vaccine.
Yesterday Moderna received a downgrade from Needham from ‘Buy’ to ‘Hold’ rating. Analysts believe that Moderna's stock is fully valued after capturing an eightfold gain this year.

Moderna (MRNA.US) stock is testing major support at $150.00 which coincides with 50 SMA (green line) and upward trendline. As long as the price sits above it, the continuation of a upward trend looks probable. The nearest key resistance lies at the $178.68 level. However if sellers will manage to break below the support zone, a downward impulse towards $129.12 could be launched. Source: xStation5

27 August 2026, 6:34 AM

⚡Morning Wrap: Nvidia wows with results again (08.26.27)

26 August 2026, 11:14 PM

Nvidia mesmerizes markets: is it too early to doubt the AI bull market?

26 August 2026, 9:39 PM

Nvidia shares react to solid earnings report and stonger guidance 🗽 What's next for the AI giant?

26 August 2026, 3:10 PM

US OPEN: Oil reverses declines despite Trump's assurances, while Wall Street awaits Nvidia's judgment report

Stocks

Prefer XTB on Google

Cookie name	Description
SERVERID
userBranchSymbol	Expiration date 1 day
test_cookie	Expiration date 1 hour
adobe_unique_id	Expiration date 364 days
__hssc	Expiration date 1 hour
SESSID	Expiration date 1 day
__cf_bm	Expiration date 1 hour
intercom-id-iojaybix	Expiration date 270 days
intercom-session-iojaybix	Expiration date 6 days
xtbCookiesSettings	Expiration date 364 days
TS5b68a4e1027
countryIsoCode
xtbLanguageSettings	Expiration date 364 days
userPreviousBranchSymbol	Expiration date 364 days
intercom-device-id-iojaybix	Expiration date 270 days
__cfruid
_cfuvid

Cookie name	Description
_gid	Expiration date 1 day
_gat_UA-98728395-1	Expiration date 1 hour
_gat_UA-121192761-1	Expiration date 1 hour
_gcl_au	Expiration date 89 days
_ga_CBPL72L2EC	Expiration date 729 days
_ga	Expiration date 729 days
__hstc	Expiration date 179 days
__hssrc
_vwo_uuid_v2	Expiration date 365 days
_ga_TC79BEJ20L	Expiration date 729 days
_vwo_uuid	Expiration date 365 days
_vwo_ds	Expiration date 29 days
_vwo_sn	Expiration date 1 hour
_vis_opt_s	Expiration date 99 days
_vis_opt_test_cookie
af_id	Expiration date 394 days
afUserId	Expiration date 730 days
AF_SYNC	Expiration date 6 days
AnalyticsSyncHistory	Expiration date 29 days

Cookie name	Description
MUID	Expiration date 389 days
_omappvp	Expiration date 3998 days
_omappvs	Expiration date 1 hour
_uetsid	Expiration date 1 day
_uetvid	Expiration date 389 days
_fbp	Expiration date 89 days
fr	Expiration date 89 days
_ttp	Expiration date 89 days
_tt_enable_cookie	Expiration date 89 days
hubspotutk	Expiration date 179 days
IDE	Expiration date 389 days
YSC
VISITOR_INFO1_LIVE	Expiration date 179 days
li_sugr	Expiration date 89 days
guest_id_marketing	Expiration date 729 days
guest_id_ads	Expiration date 729 days
guest_id	Expiration date 729 days
muc_ads	Expiration date 729 days
VISITOR_PRIVACY_METADATA	Expiration date 179 days
MSPTC	Expiration date 389 days

Cookie name	Description
bcookie	Expiration date 364 days
lidc	Expiration date 1 day
UserMatchHistory	Expiration date 29 days
bscookie	Expiration date 364 days
li_gc	Expiration date 179 days
personalization_id	Expiration date 729 days